As a Senior Associate with the Discovery, Nonclinical, and Animal Health sector of LBG, Dr. Noon functions as a force multiplier in direct technical and administrative support by integrating into existing and new project teams to execute client engagements and ensure that key deliverables and timelines are met. She provides key pharmaceutical science subject matter expertise and assists with clinical operations as programs transition between phases of the product development continuum, including study start-up activities as well as protocol development, and has completed Good Clinical Practice and Health and Human Services Human Research Protection training.
She also provides cross-functional program management and leadership support to LBG’s Government Services, Device and Diagnostics, Product Development, and Strategic Consulting sectors. Contemporary program contributions include clinical development of a novel sulfur mustard gas medical countermeasure, clinical development of an F. tularensis vaccine, and an early-stage product development of a VEEV therapeutic.
Prior to her current role, Dr. Noon served as a Health Sciences Consulting intern at LBG while completing her MBA. She supported the technical submission of proposal responses, advanced client-specific deliverables, and assisted with internal business development activities. She brings a wealth of experience from her previous internships, including positions at a life sciences commercialization consulting firm, a data and analytics consulting firm, and a clinical stage biopharmaceutical company, supporting strategic market access and intelligence, healthcare economics, pre-approval research, and targeted literature evaluation for new business development.
Dr. Noon received her Pharm.D. and her MBA from the University of Kansas.
